1-4 of 4
Jose Antonio García-Marco, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Pau Abrisqueta, MD, Neus Villamor, MD, PhD, María José Terol, MD, PhD, Eva González-Barca, MD, PhD, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose Antonio García-Marco, MD, PhD, Yolanda González, MD, Felix Carbonell, MD, PhD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, MD, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD, Francesc Bosch, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3930.
https://doi.org/10.1182/blood.V120.21.3930.3930
Published: 2012
Journal Articles

Feasability and Toxicity After Induction Treatment with Rituximab-HCVAD and Metotrexate/Citarabine, Followed by Consolidation with Y-90 Ibritumomab Tiuxetan (Phase II GELTAMO–LCM 04-02 study).

Reyes Arranz, Ana Garcia-Noblejas, MD, Carlos Grande, José Terol, Ma, José Javier Sánchez, Javier Perez-Calvo, MD, Miguel Canales, Jose Antonio García-Marco, MD, PhD, Eva Marti, Eulogio Conde, MD, Antonio Salar, MD, PhD, Dolores Caballero
Journal: Blood
Blood (2009) 114 (22): 1703.
https://doi.org/10.1182/blood.V114.22.1703.1703
Published: 2009
Journal Articles

Molecular Heterogeneity as a Basis for Rational Therapeutics in Chronic Lymphocytic Leukemia.

Beatriz Herreros, Shaomeng Wang, James Robert Bischoff, PhD, Ruben Carro, Raul Córdoba, Julio Delgado, MD, PhD, Jose Antonio García-Marco, MD, PhD, Natalia Gómez, Juan F. García, José Francisco Tomáas, Joaquín Martínez-López, Antonia Rodríguez, Raquel Villuendas, Miguel A. Piris, MD
Journal: Blood
Blood (2009) 114 (22): 2348.
https://doi.org/10.1182/blood.V114.22.2348.2348
Published: 2009
Journal Articles

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Blanca Espinet, PhD, Salaverría Itziar, PhD, Sílvia Beà, PhD, Neus Ruiz-Xivillé, Olga Balagué, MD, Marta Salido, Dolors Costa, PhD, Ana E Rodriguez, Juan LuíS. García, PhD, JesúS. M.ª Hernández-Rivas, MD, PhD, M.ª José Calasanz, PhD, Ana M Ferrer, MD, PhD, Antonio Salar, MD, PhD, Ana Carrió, PhD, Natividad Polo, Jose Antonio García-Marco, MD, PhD, Alicia Domingo, MD, Eva González-Barca, MD, PhD, Vicenç Romagosa, MD, Isabel Marugán, Armando López-Guillermo, MD, PhD, Fuensanta Millá, MD, José Luís Mate, MD, PhD, Elisa Luño, MD, PhD, Carmen Sanzo, MD, PhD, Rosa Collado, MD, PhD, Isabel Oliver, Sebastià Monzó, MD, Antonio Palacín, MD, Teresa González, Francesc Sant, MD, Ramon Salinas, MD, PhD, Mª Teresa Ardanaz, MD, Llorenç Font, MD, PhD, Lourdes Escoda, MD, Lourdes Florensa, MD, PhD, Elias Campo, MD, PhD, Sergi Serrano, MD, PhD, Francesc Solé, PhD
Journal: Blood
Blood (2008) 112 (11): 1765.
https://doi.org/10.1182/blood.V112.11.1765.1765
Published: 2008